74378. Industry
Session: Meet-the-Professor Session: Women in ID
Thursday, October 4, 2018: 7:45 AM
Room: S 155
Alejandra Gurtman, MD, Vaccine Vaccine Research and Development, Pfizer, Pearl River, NY

Alejandra Gurtman MD, VP Pfizer, Vaccine Clinical Research and Development, is the Global Clinical Lead for the Staphylococcus aureus vaccine(SA4Ag). In this role she is responsible for leading global clinical development oversight of this new vaccine including successful design of a clinical development strategy that will assure licensure of the vaccine. Before this role, Alejandra led the Prevnar 13 Pediatric Program through all phases of development. She also provided significant strategic and tactical support to the Prevnar 13 Adult Program and studies performed in high risk immunocompromised children and adults. Alejandra received her medical school and internal medicine training at the University of Buenos Aires, School of Medicine, Argentina, and postdoctoral training as fellow and chief fellow of infectious diseases at Mount Sinai School of Medicine, New York. She served on the faculty of the Mt. Sinai School of Medicine rising to Associate Professor in June 2003. In her academic role she gained experience in conduct of clinical trials, care of high risk populations, and was the director for the travel medicine program.


Disclosures:

A. Gurtman, Pfizer: Employee and Shareholder , Salary .

See more of: Women in ID
See more of: Meet-the-Professor Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.